ANTHROLOG
LIVE

Serial Number

98662116

Owner

Montai Therapeutics, Inc.

Attorney

Christina M. Licursi

Filing Date

Jul 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ANTHROLOG Trademark

Serial Number: 98662116

ANTHROLOG is a trademark filed by Montai Therapeutics, Inc. on July 23, 2024. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Montai Therapeutics, Inc. (6 trademarks)

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

July 23, 2024

Registration Date

Not Registered

Published for Opposition

April 8, 2025

Goods & Services

Providing online non-downloadable software for generating chemical compounds with targeted biological and chemical activity and drug efficacy for use in molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures in the pharmaceuticals and healthcare fields; providing on-line non-downloadable software featuring artificial intelligence for generating chemical compounds with targeted biological and chemical activity and drug efficacy for use in molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; providing on-line non-downloadable software for operating the use of artificial intelligence for discovering and designing biomolecules, chemical structures, and pharmaceuticals for use in the biotechnology field

Downloadable software for generating chemical compounds with targeted biological and chemical activity and drug efficacy for use in molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures in the pharmaceuticals and healthcare fields; downloadable software featuring artificial intelligence for generating chemical compounds with targeted biological and chemical activity and drug efficacy for use in molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; downloadable software enabling the use of artificial intelligence for discovering and designing biomolecules, chemical structures, and pharmaceuticals for use in the biotechnology field

Biological and chemical agents for scientific and research use, namely, biological and chemical preparations for use in the development and manufacture of pharmaceuticals

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 2, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jun 1, 2026 EX2G
SOU EXTENSION 2 FILED
Jun 1, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 1, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 17, 2025 EXRA
SOU EXTENSION 1 GRANTED
Nov 17, 2025 EX1G
SOU EXTENSION 1 FILED
Nov 17, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 17, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 3, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 8, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 8, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 2, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 13, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 6, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 6, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025 NWOS
NEW APPLICATION ENTERED
Jul 23, 2024 NWAP